Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
Cheng AL, Hsiung CA, Su IJ, Chen PJ, Chang MC, Tsao CJ, Kao WY, Uen WC, Hsu CH, Tien HF, Chao TY, Chen LT, Whang-Peng J; Lymphoma Committee of Taiwan Cooperative Oncology Group.
Cheng AL, et al. Among authors: hsu ch.
Hepatology. 2003 Jun;37(6):1320-8. doi: 10.1053/jhep.2003.50220.
Hepatology. 2003.
PMID: 12774010
Clinical Trial.